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Two rare G6 rotavirus A (RVA) strains, desig-
nated as RVA/human-wt/ITA/CEC06/2011/G6P
[6] and RVA/human-wt/ITA/PG05/2011/G6P[9],
were identified in stool specimens from chil-
dren hospitalized in Central Italy. After PCR
genotyping, the samples CEC06 and PG05
gave G-UD-P[6] and G-UD-P[9] genotypes, re-
spectively. To determine the G-type and to
characterize further the two strains, sequencing
of 8 of the 11 genomic segments was per-
formed. CEC06 and PG05 strains were found
to possess unusual genotype constellations:
G6-P[6]-I2-A2-N2-T2-E2-H2 and G6-P[9]-I2-A3-
N2-T3-E3-H3, respectively. This study reports
the first detection of rare G6P[6] and G6P[9]
RVA strains in peninsular Italy. Phylogenetic
analysis of VP4 (VP8), VP7, VP6, and NSP1-5
showed no evidence of zoonosis or inter-
species reassortment, revealing for both strains
constellations previously associated to human
cases. J. Med. Virol. 85:1860–1869, 2013.
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INTRODUCTION
Group A rotaviruses (RVA) are the leading cause of
acute gastroenteritis (GE) in young (<5 years of age)
children, causing approximately 450 000 deaths
worldwide, mostly in developing countries [Tate et al.,
2012]. RVA virions consist of icosaedral, triple-
layered, and non-enveloped particles possessing a
segmented genome made of 11 double-stranded RNA
linear segments [Estes and Cohen, 1989]. The RVA
outer layer is composed of two proteins, VP7 and
VP4, expressed by gene 9 and 4, respectively. VP7
(G-type) and VP4 (P-type) genotypes are the basis for
the binary RVA nomenclature [Hoshino et al., 1985].
Although at least 27 G-types and 37 P-types of
rotavirus have been reported [Matthijnssens et al.,
2011; Trojnar et al., 2013], most of RVA infections in
humans worldwide are related to five major G/P
combinations: G1P[8], G2P[4], G3P[8], G4P[8], and
G9P[8] [Gentsch et al., 2005]. However, besides
strains common worldwide such as G1P[8], G3P[8],
and G9P[8], human RVA genotypes circulating in the
African countries also include strains which are
unconventional in Europe and in other developed
areas of the world, with a particularly high preva-
lence of G2P[6] and G8P[6] [Santos and Hoshino,
2005; Todd et al., 2010]. Facing the unusual and
emerging RVA combinations that are increasingly
reported in humans, a new nomenclature system has
been adopted, based on nucleotide sequences and
genotypes of each of the 11 genomic segments
[Matthijnssens et al., 2008a]. This system facilitates
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investigation of the origin of new and potentially
epidemic RVA genotypes, and the evolutionary mech-
anisms these undergo from interspecies transmission
through adaptation to human hosts, including gene
reassortment [Martella et al., 2010].
Despite the large number of genotypes established
for both VP7 and VP4 genomic segments, comprehensive
analysis of sequences for the entire rotavirus genome
available in GenBank suggests that in the majority of
cases rotaviruses can be assigned to two main constella-
tions of genotypes, corresponding to previously known
subgroup I and II of rotavirus prototype strains, Wa and
DS-1 [Kalica et al., 1981]. The former exhibits the G1-P
[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1 formulation, and the
latter is reported as G2-P[4]-I2-R2-C2-M2-A2-N2-T2-E2-
H2 [Matthijnssens et al., 2011].
In addition, the unique rotavirus strain AU-1 found
in Japan in 1985 [Matthijnssens and Van Ranst,
2012] is indicated as G3-P[9]-I3-R3-C3-M3-A3-N3-T3-
E3-H3.
In 2006, two RVA vaccines were licensed for
human use, and both are now used in an increasing
number of countries worldwide. Their antigenic com-
positions are based on the commonest RVA genotypes
circulating worldwide, the monovalent vaccine
Rotarix1 being based on human G1 and P[8] antigen
specificities, whereas the bovine-derived pentavalent
reassortant vaccine Rotateq1 is based on G1, G2, G3,
G4, and P[8] antigens [Ruiz-Palacios et al., 2006;
Vesikari et al., 2006; Linhares et al., 2008]. The
efficacy of both vaccines is very high against diar-
rhoea caused by the common rotavirus strains,
including G9 RVA which has emerged and spread
rapidly in the 2000s, and has now established as a
major global genotype in humans [Santos and
Hoshino, 2005; Gentsch et al., 2009; Matthijnssens
et al., 2010; Iturriza-Gomara et al., 2011].
Recently, novel uncommon RVA genotypes such as
G6, G8, and G12, in association with P[6], P[8], and
P[14], have been reported in sporadic cases of GE in
several countries, particularly in developing areas
[Gerna et al., 1994; Iturriza Gomara et al., 2004;
Matthijnssens et al., 2006; Matthijnssens et al., 2010;
Nordgren et al., 2012b]. Due to their unconventional
G- and P-genotypes, these are regarded as possible
epidemic strains potentially able to escape the im-
mune protection sustained by current vaccines [Offit
and Dudzik, 1988; Ijaz et al., 1991; Dunn et al., 1995;
Ward et al., 2006]. These strains are possibly gener-
ated through animal–human transmission involving
reassortment events with multiple strain infections
[Martella et al., 2010].
During the surveillance activity of RotaNet-Italy,
two RVA strains with unusual G/P combinations
G6P[6] and G6P[9] were found in two distinct cities
of Central Italy in 2011 [Ruggeri et al., 2011]. To
understand better their origin, the two strains were
subjected to sequencing of the genes encoding for the
main structural proteins VP7, VP4, and VP6, and for
the non-structural proteins NSP1-5.
MATERIALS AND METHODS
Clinical Cases, and RVA Identification
Stool specimens were collected on admission from
two children with severe disease, aged 10 months
and 21 months, respectively, who were admitted with
acute GE to public hospitals of Cecina (Tuscany) and
Perugia (Umbria), in 2011. Clinical information was
obtained from the anamnesis forms of the RotaNet-
Italy surveillance project filled by the pediatric units,
in compliance with the Informed Consensus Agree-
ment. Additional information including patients’
histo-blood group (routinely performed according to
the hospital standard operative procedures for
patients’ management) was supplied by personal
communications with the parents of both children.
Rotavirus infection was diagnosed at the hospital
pediatric units by the commercial antigen detection
methods in daily use.
Reverse Transcription-Polymerase Chain
Reaction and Nucleotide Sequencing
Total viral RNA was extracted from 140 ml of 10%
fecal suspensions in H2O, using the Viral RNeasy
Mini Kit (Qiagen, Milan, Italy), according to the
manufacturers’ instructions. RNA was eluted in 60 ml
of RNase-free water, and stored at 80˚C until use.
G- and P-genotyping was performed by reverse
transcription nested polymerase chain reaction
(RT-nPCR), using mixtures of primers for either gene
9 and 4, as described previously [Gentsch et al., 1992;
Iturriza-Gomara et al., 2004]. RT-PCR was performed
with the Access RT-PCR kit (Promega, Madison, WI)
following the manufacturers’ instructions.
For sequence analysis, RT-PCR reactions included
primers specific for each of the eight genes investigat-
ed [Matthijnssens et al., 2008a], using a Tm of 50˚C
for all the reactions. A 3 min elongation step was
used to obtain VP4 (VP8), VP7, and NSP2-5 ampli-
cons, whereas for VP6 and NSP1, elongation was
protracted for 6 min. PCR products were visualized
under UV light after electrophoretic separation on a
2% agarose gel stained with ethidium bromide.
Nucleotide sequencing of genes amplified was per-
formed by Macrogen, Inc. (Seoul, South Korea), using
the same primers used for PCR. The sequencing
reaction was based on the BigDye chemistry, and all
sequences were performed twice.
Software Analysis
The sequencing files obtained were analyzed and
corrected with ChromaPro 2.23 (Technelysium,
Queensland, Australia), and consensus sequences
were obtained using SeqMan II (DNASTAR, Madison,
WI). Multiple sequence alignments, phylogenetic
analysis and analysis of the amino acids within the
VP8 binding domain were performed using the
MEGA5 software (www.megasoftwares.com).
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Sequences obtained in this study are available
in GenBank (http://www.ncbi.nlm.nih.gov/genbank/)
under the following accession numbers:
CEC06_VP8 Acc. Num. KC152908; CEC06_VP7 Acc.
Num. KC152909; CEC06_VP6 Acc. Num.
KC152910; CEC06_NSP1 Acc. Num. KC152911;
CEC06_NSP2 Acc. Num. KC152912; CEC06_NSP3
Acc. Num. KC152913; CEC06_NSP4 Acc. Num.
KC152914; CEC06_NSP5 Acc. Num. KC152915.
PG05_VP8 Acc. Num. KC152916; PG05_VP7 Acc.
Num. KC152917; PG05_VP6 Acc. Num. KC152918;
PG05_NSP1 Acc. Num. KC152919; PG05_NSP2
Acc. Num. KC152920; PG05_NSP3 Acc. Num.
KC152921; PG05_NSP4 Acc. Num. KC152922;
PG05_NSP5 Acc. Num. KC152923.
PG01_VP8 KC152924; PG01_VP7 Acc. Num.
KC152925; PG01_VP6 Acc. Num. KC152926;
PG01_NSP1 Acc. Num. KC152927; PG01_NSP2
Acc. Num. KC152928; PG01_NSP3 Acc. Num.
KC152929; PG01_NSP4 Acc. Num. KC152930;
PG01_NSP5 Acc. Num. KC152931.
RESULTS
Two unconventional rotaviruses were detected in
the stools of a child born in Cecina, Tuscany, to
Senegalese parents (CEC06/2011), and of a child born
in Perugia, Umbria, to Rumanian parents (PG05/2011).
Both children were less than 1 year old, had not
received rotavirus vaccination, and were admitted to
public hospitals with a diagnosis of acute GE and
dehydration. The child from Cecina presented acute
osmotic shock, with severe risk for his life. The
disease course was normal in both cases, with no
complication after the oral rehydration therapy. Both
children belonged to the A-type histo-blood group.
Neither children had history of travel to their country
of origin, nor did they have animals at home.
After the first cycle of PCR genotyping, the G/P
combination found for the strains was G-UD-P[6] and
G-UD-P[9], respectively.
In both cases, the VP7 genotype was determined
following sequence analysis of the full gene 9 RT-PCR
product, yielding G6P[6] for strain RVA/human-wt/ITA/
CEC06/2011, and G6P[9] for strain RVA/human-wt/
ITA/PG05/2011.
In addition to genomic segments 9 and 4, genome
segments encoding VP6 and NSP1-5 were also ampli-
fied by RT-PCR, and subjected to nucleotide sequenc-
ing. Although a full-genome sequencing was not
performed for the two Italian strains, analysis of 8
of their 11 genomic segments permitted to address
possible reassortment involving large part of the viral
genes. The genotyping and phylogenetic analysis of
the eight genes investigated for strains RVA/human-
wt/ITA/CEC06/2011 and RVA/human-wt/ITA/PG05/
2011 revealed the presence of two distinct human
RVA genomic constellations not detected previously
in Italy: that is, G6-P[6]-I2-A2-N2-T2-E2-H2 and
G6-P[9]-I2-A3-N2-T3-E3-H3 (Fig. 1a–h).
The VP7 tree (Fig. 1a) revealed that the two Italian
G6 strains clustered strictly together in a cluster that
included the human G6 strains reported during the
last 10 years in Europe, Japan, and Africa, showing
the highest nucleotide similarity among all genes
investigated (96%). The VP4 (VP8) tree (Fig. 1b)
showed that the CEC06/2011 rotavirus belonged to
the P[6] genotype, clustering strictly with P[6] strains
circulating in Africa, Bangladesh, Belgium, and USA,
whereas strain PG05/2011 clustered in the P[9]
group, with a gene 4 closely similar to several human
G3P[9] and G6P[9] strains, identified either in Japan
or in the Italian island of Sicily, and to a feline G3P
[9] strain reported in Southern Italy.
In addition to VP7, strains CEC06/2011 and PG05/
2011 shared the same genotype only for VP6 and
NSP2 (Fig. 1c and e), but they appeared to belong
to two different clusters, presenting a low similarity
rate (i.e., 92% and 90%).
Phylogenetic analysis of NSP1 and NSP3-5
(Fig. 1d, f–h) revealed that the two Italian strains
clustered separately because of their different geno-
type: strain CEC06/2011 belonged to the genotype 2
for all genes, whereas strain PG05/2011 genes clus-
tered consistently with the genotype 3 group.
In all trees, strain CEC06/2011 showed the highest
similarity with the G6P[6] strains identified in
Burkina Faso (BFA) in 2010 (similarities between
99% and 100%) [Nordgren et al., 2012b], whereas
strain PG05/2011 correlated strictly with the 2010
Japanese strain KF17 [Yamamoto et al., 2011].
To address possible interspecies reassortments
involving the Italian G6 strains, a typical DS-1 like
strain circulating in Central Italy in 2011 (RVA/
human-wt/ITA/PG01/2011/G2P4) was also sequenced,
and used for comparison in each phylogenetic tree.
RVA/human-wt/ITA/PG01/2011/G2P4 showed the
same genotype as CEC06/2011 for VP6 and the NSPs
(G2-P[4]-I2-A2-N2-T2-E2-H2). Obviously, it clustered
as an outgroup in the VP7 and VP4 trees, and also
showed major difference with the G6P[9] strain
PG05/2011 for all the genes grouped in genotype 3
clusters. In the NSP1, NSP3, and NSP5 trees, the
G2P[4] strain PG01/2011 showed strong similarity
(99%) with G6P[6] strain CEC06/2011; conversely, in
trees corresponding to VP6, NSP2, and NSP4, strain
PG01/2011 clustered separately from strain CEC06/
2011 (96%, 90%, and 92% similarities), while showing
close relatedness to strains GER1H-09 [Pietsch et al.,
2009], DRC86 and DRC88 [Matthijnssens et al.,
2006] (Fig. 1a–h).
The amino acid homology of the VP8 gene of G6P
[6] (CEC06/2011) and G6P[9] PG05/2011 strains was
investigated with respect to the reference P[6] and P
[9] strains recently shown to bind specific carbohy-
drates involved in cell binding [Hu et al., 2012;
Huang et al., 2012]. The G6P[6] strain CEC06/2011
shared an overall similar VP4 amino acid sequence
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with the reference P[6] RVA strains, and in particu-
lar it shared identical I101, D187, Y188, S189, S190,
and T191 amino acids (numbering based on RRV
VP8 sequence AY033150.1), which are residues
involved in the rotavirus VP8 binding cleft. However,
the Italian strain presented a deletion at position
134. In the same cleft region, the G6P[9] strain
PG05/2011 showed four different amino acids out of
six (R101, S187, Y188, Y189, L190, T191) with
respect to the G6P[6] CEC06/2011 strain, whereas it
shared the same residues identified in the G6P[14]
strain HAL1166, identified originally in 1994 in Finland
[Gerna et al., 1994], and reported recently to bind
A-type histo-blood cellular antigens [Hu et al., 2012].
DISCUSSION
This study represents the first report in Italy, and
the second in Europe [Matthijnssens et al., 2008b], of
a human G6P[6] RVA strain, whereas G6P[9] RVA
has previously been reported sporadically in Italy,
having caused four infantile GE cases between
1986 and 2003 in Sicily [De Grazia et al., 2011].
Nonetheless, strain PG05/2011 represents the first
case of a G6P[9] genotype circulating in the whole of
peninsular Italy.
No other similar genotypes were found from any
other children with RVA GE in the same areas in
2011, where most of patients were infected with G1P
[8] rotaviruses or, to a lesser extent, with other
common G/P genotypes (not shown).
Results of the phylogenetic analysis refute the
possibility that the two Italian G6 strains could
Fig. 1. Phylogenetic trees based on the nucleotide sequence of the entire ORF of genes
encoding for: (a) VP7, (b) VP4 (VP8), (c) VP6, (d) NSP1, (e) NSP2, (f) NSP3, (g) NSP4, and (h)
NSP5. G6 strains CEC06/2011 and PG05/2011 are marked with a filled circle; reference DS-1
like strain is marked with a filled triangle. Trees were built with the neighbor-joining method
and bootstrapped with 1,000 repetitions; bootstrap values below 70 are not shown. The Kimura-
2 substitution model was used, as suggested by the MEGA5 ModelTest for best-fit evolutionary
model selection. The bar indicates nucleotide substitutions per site.
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Fig. 1. (Continued)
J. Med. Virol. DOI 10.1002/jmv
1864 Ianiro et al.
have originated from recent zoonotic reassortments
between animal and human RVA strains. In fact, the
VP7 G6 genotype of both strains CEC06/2011 and
PG05/2011 corresponds closely to the G6 strains that
circulated among humans during the last 10 years
globally, and are probably derived from an earlier
reassortment event with a bovine RVA donor.
Similar conclusions can also be reached from the
analysis of the other genomic segments investigated,
in that, the two Italian G6 strains reflect pre-existing
RVA genotype constellations adapted to humans, not
detected previously in Italy. Compared to a common
DS-1 like G2P[4] RVA identified in the same area in
2011 (PG01/2011), it appears that although it shares
a DS-1 like constellation strain CEC06/2011 repre-
sents a different rotavirus lineage, with marked
differences particularly in VP6, NSP2, and NSP4
genomic segments. The G6P[9] strain PG05/2011
appears even more different in that it exhibited a
mixed constellation not sharing any gene with the
Italian G2P[4] RVA detected in the same city, during
the same period.
Fig. 1. (Continued)
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Compared to global strains, the G6P[6] strain
CEC06/2011 was found to be very close to the G6P[6]
viruses circulating in Burkina Faso in 2010 [Nordg-
ren et al., 2012b], whereas the G6P[9] strain PG05/
2011 was found to be closely similar to strain KF17,
reported in Japan in 2010 [Yamamoto et al., 2011].
The detection of a G6P[6] strain in Italy is remark-
able, considering that similar G6P[6] strains were
responsible for 11% and 23% of the severe paediatric
rotavirus GE cases, occurred in the urban and rural
areas of a main town of Burkina Faso, respectively,
resulting as the second most prevalent RVA genotype
in that area [Nordgren et al., 2012a,b]. In light of its
possible epidemic potential and because neither G6
nor P[6] are present in current vaccine formulations,
it is obvious to argue whether similar emerging
rotavirus strains would be contrasted effectively by
either Rotarix1 and Rotateq1.
The very high sequence similarity between strain
CEC06/2011 and the G6P[6] RVA reported in Burkina
Faso 1 year earlier [Nordgren et al., 2012b] suggests
that this strain may have been imported to Italy
Fig. 1. (Continued)
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as such. Nonetheless, it cannot be excluded that
multiple reassortment events between variant genes
of human and animal strains occurring sporadically
in Italy may have also influenced the genome constel-
lation of this specific strain, at least partially. The ill
child infected with the G6P[6] CEC06/2011 strain
was born from Senegalese parents, living within an
African community in the city of Cecina. Although
the patient had no history of travelling to Africa, it is
possible that some members of the community have
carried this RVA strain upon returning from their
country of origin, eventually transmitting infection to
surrounding citizens.
Strain PG05/2011 represents the second report
worldwide of a G6P[9] genotype in association with
an unusual mix of genomic constellations 2 and 3,
the other strain having been reported recently in
Japan [Yamamoto et al., 2011]. In both instances,
RVA were detected in sporadic cases of disease, and
were not related to epidemic outbreaks. The G6P[9]
rotaviruses detected in Japan were suggested to
represent a possible reassortment among uncommon
bovine-like human RVA and human/feline AU-1-like
RVA [Yamamoto et al., 2011]. Due to the quasi-
identity between the Italian and Japanese strains in
all eight genome segments sequenced, it is hard to
believe that the G6P[9] strain PG05/2011 is an
autochthonous strain generated in Italy. Rather, it is
more likely that this strain was imported as such
from Japan or that both the Italian and Japanese
strains shared a common origin from a third country,
events that should have occurred sufficiently close in
time not to allow significant evolutionary divergence
between the two strains.
The Italian patient infected with strain PG05/2011
lived in Perugia, which is renowned for the presence
of a prestigious University open to foreigners. In fact,
many Japanese students live in that town usually,
and the G6P[9] virus might have been imported
directly from Japan, possibly carried by an asymp-
tomatic adult.
The amino acid sequence analysis of the VP8
region of the Italian G6P[6] and G6P[9] strains shows
a marked difference between the two strains, as well
as the strict similarity of these strains with other
sialidase-insensitive P[6] or P[9] RVAs, respectively,
investigated recently for the capacity to bind alterna-
tive cell receptors in a genotype-specific manner
[Hu et al., 2012; Huang et al., 2012]. These research-
ers [Huang et al., 2012] proposed that P[6] rotavirus
binding to H type 1 antigens could preferentially
affect Afro Americans, among which they found this
HBGA antigen to be particularly spread, based on
previous unpublished studies. Although we cannot
exclude that such a mechanism might also apply to
the Italian G6P[6] strain, no information could be
obtained regarding the actual expression of H1 anti-
gen or the secretor status in the patient infected with
this strain in Cecina. The patient infected with the
G6P[9] RVA strain PG05/2011 belonged to the A-type
histo-blood group, that was demonstrated to bind the
VP4 of genotype P[9] as well as P[14] rotaviruses
[Hu et al., 2012].
Fig. 1. (Continued)
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Overall, this study confirms that uncommon rotavi-
rus strains can be introduced sporadically into a
country, from remote areas of other continents. In
contrast to the usual high rate of reassortment and/or
genetic drift observed among rotaviruses co-circulating
in a specific area, these unusual G6 RVA strains seem
to be highly conserved, an observation that may
either indicate a very recent importation from other
countries or suggest that the maintenance of their
overall gene constellation is necessary for them to
infect humans efficiently. In addition, possible specif-
ic host genetic constraints influencing virus binding
might limit spread of these viruses within smaller
subpopulations, hampering further virus evolution.
This might explain why no major spread of uncom-
mon African rotavirus genotypes has been observed
in Italy this far, despite the increasing international
travelling and major immigration flows across the
Mediterranean Sea.
Notwithstanding, the risk of importing novel RVA
genotypes should not be neglected, particularly as
RVA vaccination in some countries of Africa appears
to be less efficacious than in industrialized countries
[Madhi et al., 2010; Sow et al., 2012]. This may be
related at least partially to the circulation of atypical
genotypes in Africa, such as G6 and G8 in association
with different P-types, not present in vaccines formu-
lation. Together with other G and P types, the G6
RVA strains detected in Italy may thus represent a
threat, and continuation of molecular surveillance
and virus tracking programs may help prevent possi-
ble epidemic expansion of emerging strains.
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